-
Signature
-
/s/ Thomas J. Wilson
-
Issuer symbol
-
ALL
-
Transactions as of
-
02 Feb 2026
-
Net transactions value
-
-$3,373,324
-
Form type
-
4
-
Filing time
-
04 Feb 2026, 17:17:00 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| WILSON THOMAS J |
Chairman, President & CEO, Director |
C/O THE ALLSTATE CORPORATION, 3100 SANDERS ROAD, NORTHBROOK |
/s/ Thomas J. Wilson |
04 Feb 2026 |
0001190466 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ALL |
Common Stock |
Sale |
$319,028 |
-1,605 |
-1.7% |
$198.77 |
92,803 |
02 Feb 2026 |
Direct |
F1, F2 |
| transaction |
ALL |
Common Stock |
Sale |
$313,718 |
-1,572 |
-1.7% |
$199.57 |
91,231 |
02 Feb 2026 |
Direct |
F2, F3 |
| transaction |
ALL |
Common Stock |
Sale |
$2,668,235 |
-13,271 |
-15% |
$201.06 |
77,960 |
02 Feb 2026 |
Direct |
F2, F4 |
| transaction |
ALL |
Common Stock |
Sale |
$72,342 |
-359 |
-0.46% |
$201.51 |
77,601 |
02 Feb 2026 |
Direct |
F2, F5 |
| holding |
ALL |
Common Stock |
|
|
|
|
|
31,900 |
02 Feb 2026 |
By 2024-C GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
69,822 |
02 Feb 2026 |
By 2025-A GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
94,729 |
02 Feb 2026 |
By 2025-E GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
7,683 |
02 Feb 2026 |
By 401(k) Plan |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
324,088 |
02 Feb 2026 |
By 2020 GRAT Remainder Trust |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
257,535 |
02 Feb 2026 |
Remainder GRAT |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: